ENCRT Trademark
Trademark Overview
On Thursday, December 28, 2023, a trademark application was filed for ENCRT with the United States Patent and Trademark Office. The USPTO has given the ENCRT trademark a serial number of 98333363. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, November 26, 2024. This trademark is owned by Encellin, Inc.. The ENCRT trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:
Pharmaceutical products for treatment of chronic diseases by means of gene and cell therapy, encapsulated cell therapy, and implantable cell therapy; living cells for implantable cell therapy; living cells for gene and cell therapy, encapsulated cell therapy, and implantable cell therapy; living cells for medical use, namely, implantable cell therapy preparations with encapsulated cells for secreting drugs and/or molecules
Cell encapsulation devices in the nature of implantable cell therapy delivery ports; implantable cell encapsulation devices in the nature of implantable cell therapy delivery ports; implantable cell therapy devices in the nature of implantable cell therapy delivery ports
General Information
| Serial Number | 98333363 |
| Word Mark | ENCRT |
| Filing Date | Thursday, December 28, 2023 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Tuesday, November 26, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, November 26, 2024 |
Trademark Statements
| Goods and Services | Pharmaceutical products for treatment of chronic diseases by means of gene and cell therapy, encapsulated cell therapy, and implantable cell therapy; living cells for implantable cell therapy; living cells for gene and cell therapy, encapsulated cell therapy, and implantable cell therapy; living cells for medical use, namely, implantable cell therapy preparations with encapsulated cells for secreting drugs and/or molecules |
| Goods and Services | Cell encapsulation devices in the nature of implantable cell therapy delivery ports; implantable cell encapsulation devices in the nature of implantable cell therapy delivery ports; implantable cell therapy devices in the nature of implantable cell therapy delivery ports |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, February 1, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, February 1, 2024 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Encellin, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Palo Alto, CA 94304 |
| Party Name | Encellin, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Palo Alto, CA 94304 |
Trademark Events
| Event Date | Event Description |
| Wednesday, January 3, 2024 | NEW APPLICATION ENTERED |
| Thursday, February 1, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, July 26, 2024 | ASSIGNED TO EXAMINER |
| Sunday, August 4, 2024 | NON-FINAL ACTION E-MAILED |
| Sunday, August 4, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Sunday, August 4, 2024 | NON-FINAL ACTION WRITTEN |
| Thursday, October 3, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, October 3, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, October 3, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, November 4, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, November 20, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, November 26, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, November 26, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
